In-Vitro Diagnostics Instruments Market Outlook 2026–2030 Driven By Growth Factors And Projections
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, What Market Size Is The In-Vitro Diagnostics Instruments Market Expected To Reach Based On Its 2026 Value?
The in-vitro diagnostics instruments market size has shown robust expansion in recent years. It is anticipated to increase from $61.09 billion in 2025 to $67.18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.0%. The expansion observed historically is attributable to factors including the rising prevalence of chronic diseases, an increase in hospital lab infrastructure, advancements in diagnostic reagents, growing awareness for early disease detection, and government healthcare initiatives.
The in-vitro diagnostics instruments market is projected for swift expansion in the upcoming years. This market is set to reach $99.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.3%. Key drivers for this growth during the forecast period include technological progress in molecular diagnostics, the rise of personalized medicine, the incorporation of AI into diagnostic procedures, the development of healthcare in emerging markets, and the increasing need for home-based diagnostic solutions. Significant trends anticipated in the forecast period encompass the broadening of point-of-care testing, individualized diagnostics, the embrace of rapid molecular testing, the incorporation of remote patient monitoring, and the advent of miniaturized lab instruments.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Primary Drivers Are Impacting The In-Vitro Diagnostics Instruments Market Growth?
The increasing incidence of chronic and lifestyle-related diseases is anticipated to fuel the expansion of the in vitro diagnostics instruments market in the future. Chronic and lifestyle-related diseases refer to enduring health conditions primarily influenced by daily behaviors, habits, and environmental elements, encompassing illnesses like heart disease, diabetes, obesity, and specific cancers. These conditions are on the rise due to inactive lifestyles and poor dietary choices. As these chronic and lifestyle-related diseases spread rapidly, driving companies to adopt early detection and monitoring solutions for improved disease management, the in vitro diagnostics instruments solutions are experiencing heightened demand. For instance, in 2024, the American Action Forum, a US-based non-profit, center-right think tank, noted that chronic diseases remain a significant public health concern in the U.S., with close to 60 percent of adults living with at least one condition, 40 percent managing multiple conditions, and the prevalence is expected to nearly double by 2050. Additionally, the chronic disease treatment market is projected to reach approximately USD 38.02 billion by 2034, marking a substantial rise from USD 9.74 billion in 2025. Therefore, the growing prevalence of chronic and lifestyle-related diseases is a key factor driving the demand for the in vitro diagnostics instruments market.
What Are The Different Segment Types In The In-Vitro Diagnostics Instruments Market Segment Breakdown?
The in-vitro diagnostics instruments market covered in this report is segmented –
1) By Product Type: Clinical Chemistry, Immunoassay, Molecular Diagnostics, Hematology, Microbiology, Coagulation, Other Product Types
2) By Application: Infectious Diseases, Cancer, Cardiology, Nephrology, Autoimmune Diseases, Other Applications
3) By End User: Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Point-Of-Care Settings, Blood Banks, Pharmaceutical And Biotechnology Companies, Other Healthcare Facilities
Subsegments:
1) By Clinical Chemistry: Automated Clinical Chemistry Analyzers, Semi-Automated Clinical Chemistry Analyzers, Point-Of-Care Clinical Chemistry Devices
2) By Immunoassay: Enzyme-Linked Immunosorbent Assay (ELISA) Systems, Chemiluminescence Immunoassay (CLIA) Analyzers, Radioimmunoassay (RIA) Systems
3) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Deoxyribonucleic Acid Microarrays, Isothermal Amplification Devices
4) By Hematology: Automated Hematology Analyzers, Manual Hematology Analyzers, Hemostasis Analyzers, Coagulation Analyzers
5) By Microbiology: Microbial Identification Systems, Antibiotic Susceptibility Testing (AST) Systems, Blood Culture Systems, Automated Microbial Analyzers.
6) By Coagulation: Coagulometers, Platelet Function Analyzers, Thromboelastography (TEG) Systems, Point-Of-Care Coagulation Devices
7) By Other Product Types: Point-Of-Care Diagnostic Devices, Miscellaneous Laboratory Instruments
Which Trends Are Shaping Growth In The In-Vitro Diagnostics Instruments Market?
Leading companies in the in-vitro diagnostics instruments market are concentrating on developing advanced products, such as digital polymerase chain reaction (dPCR) systems, to achieve highly precise and sensitive nucleic acid quantification essential for advanced diagnostics. Digital polymerase chain reaction (dPCR) systems are sophisticated diagnostic tools that accurately quantify DNA or RNA molecules by separating samples into thousands of individual reactions, ensuring highly accurate and sensitive detection. For example, in September 2024, QIAGEN N.V., a Netherlands-based biotechnology company, introduced the QIAcuityDx Digital PCR System, broadening its digital PCR portfolio into clinical diagnostics with a particular emphasis on oncology testing. This fully integrated, automated system is specifically designed for clinical testing in oncology, featuring a cartridge-based workflow that significantly reduces hands-on time. The QIAcuityDx also incorporates automated analysis and reporting software, which allows for the rapid and accurate detection of genetic biomarkers for cancer diagnosis and therapy monitoring without requiring extensive operator intervention.
Who Are The Well-Known Companies In The In-Vitro Diagnostics Instruments Market?
Major companies operating in the in-vitro diagnostics instruments market are F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Becton Dickinson and Company, Sysmex Corporation, Bio-Rad Laboratories Inc, Agilent Technologies, Hologic Inc, Qiagen N.V., Illumina Inc, Ortho Clinical Diagnostics, Beckman Coulter Inc, Mindray Medical International Limited, Horiba Ltd, Randox Laboratories Ltd, DiaSorin S.p.A., Werfen S.A., Trinity Biotech plc
Get The Full In-Vitro Diagnostics Instruments Market Report:
Which Region Leads The In-Vitro Diagnostics Instruments Market In Terms Of Market Share?
North America was the largest region in the in-vitro diagnostics instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro diagnostics instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized In-Vitro Diagnostics Instruments Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global In-Vitro Diagnostics Instruments Market 2026, By The Business Research Company
Intravenous Iv Hydration Therapy Market Report 2026
Intravenous Immunoglobulin Market Report 2026
https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report
Intravenous Infusion Pumps Market Report 2026
https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
